XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 26, 2021
Jun. 27, 2020
Jun. 26, 2021
Jun. 27, 2020
Income Statement [Abstract]        
Net sales $ 523,488 $ 307,337 $ 987,282 $ 653,433
Cost of sales 326,092 207,435 629,420 429,175
Gross profit 197,396 99,902 357,862 224,258
Selling, general, and administrative expenses 73,315 53,199 131,603 104,399
Research and development expenses 16,394 13,161 31,133 27,624
Amortization of intangibles 10,641 9,827 21,162 19,808
Restructuring, impairment, and other charges 789 35,665 1,226 39,627
Total operating expenses 101,139 111,852 185,124 191,458
Operating income (loss) 96,257 (11,950) 172,738 32,800
Interest expense 4,626 5,855 9,299 11,273
Foreign exchange (gain) loss (1,676) (6,010) 5,161 (3,426)
Other (income) expense, net (1,890) (1,210) (9,627) 39
Income (loss) before income taxes 95,197 (10,585) 167,905 24,914
Income taxes 13,102 (1,594) 28,097 9,261
Net income (loss) $ 82,095 $ (8,991) $ 139,808 $ 15,653
Earnings (loss) per share:        
Basic (in dollars per share) $ 3.34 $ (0.37) $ 5.69 $ 0.64
Diluted (in dollars per share) $ 3.30 $ (0.37) $ 5.62 $ 0.64
Weighted-average shares and equivalent shares outstanding:        
Basic (in shares) 24,592 24,312 24,562 24,353
Diluted (in shares) 24,900 24,312 24,894 24,520